Parkinsn's Email List Message

Posting to the Parkinsn List is a benefit of Subscription


[Message Prev][Message Next][Thread Prev][Thread Next][Message Index][Thread Index]

CSRINDX OCT 98 Part 3 of 3


"                 Neur                1997;49:1262-1267 Jan 98
     "                 Neur                1997;49:1424-1431 Jan 98
     "                 Arch Neur           1998;55:84-90     Feb 98
Ondansetron (Zofran)   Neur                1995;45:1305-1308 Oct 95
     "                 Neur                1996;47:1608-1609 Feb 97
     "  , for tremor   J Neur N'surg Psych 1997;62:282-284   Apr 97
On-off effect          J Neur N'surg Psych 1995;59:555       Dec 95
     "                 J Neur N'surg Psych 1996;61:634-637   Aug 96
Onset, early vs late   Mov Disord          1997;12:277-284   Aug 97
  "  ,   "             Neur                1998;50:1340-1345 Jul 98
Osteoporosis           Neur                1997;49:1272-1278 Jan 98
Oxidative stress       Neur                1995;45S3:55      May 95
     "                 J Neur N'surg Psych 1995;59:90-91     Aug 95
     "                 Ann Neur            1996;39:378-381   Apr 96
     "                 Mov Disord          1998;13S1:24-34   Jul 98
Pallidopyramidal       Ann Neur            1995;38:954-956   Feb 96
Pallidotomy, boom in   WSJ                 22 Feb 95:1       Mar 95
     "      , benefits Neur                1995;45:753-761   Jun 96
     "      ,    "     Lancet              25 May 1996:1490  Jul 96
     "      ,    "     Ann Neur            1996;39:826       Jul 96
     "      ,    "     J Neur N'surg Psych 1997;62:125-132   Apr 97
     "      ,    "     Lancet              15 Mar 1997:777   Apr 97
     "      ,    "     Neur                1997;48:1273-1277 Jun 97
     "      ,    "     Ann Neur            1997;41:834       Jul 97
     "      ,    "     Arch Neur           1997;54:1026-1029 Oct 97
     "      ,    "     J Neurosurg         1997;87:358-367   Oct 97
     "      ,    "     Neur                1997;49:1072-1077 Nov 97
     "      ,    "     Neur                1998;50:266-270   Feb 98
     "      ,    "     Arch Neur           1998;55:1201-1208 Oct 98
     "     , cognition Arch Neur           1997;54:947-950   Sep 97
     "     ,     "     Neur                1998;51:207-215   Aug 98
     "     ,     "     Arch Neur           1998;55:881-883   Aug 98
     "     ,     "     J Neur N'surg Psych 1998;65:148       Sep 98
     "     ,     "     J Neur N'surg Psych 1998;65:150-154   Sep 98
     "       and DBS   Nat Med             1997;3:671-674    Jul 97
     "           "     Nat Med             1997;3:602-603    Jul 97
     "           "     Neur                1997;49:1078-1083 Nov 97
     "  for dystonia   Mov Disord          1997;12:865-870   Jan 98
     "   "      "      Mov Disord          1998;13:693-698   Sep 98
     "     , effects   J Neur N'surg Psych 1997;63:150-162   Oct 97
     "     ,    "      Neur                1997;49:1278-1283 Jan 98
     "     ,    "      Brain               1998;121:50-75    Mar 98
     "     ,    "      Neur                1998;50:434-438   Mar 98
     "     ,    "      Clin Neuropharm     1998;21:135-138   Jun 98
     "     ,    "      Brain               1998;121:659-675  Jun 98
     "     ,    "      Mov Disord          1998;13S1:73-82   Jul 98
     "  , gamma knife  Ann Neur            1996;39:535-538   Jun 96
     "  ,     "        J Neurosurg         1998;89:183-193   Sep 98
     "     , history   Ann Neur            1996;40:341-343   Oct 96
     "     ,    "      BMJ                 25 Apr 98:1259-60 Jun 98
     "     ,    "      Mov Disord          1998;13:582-588   Jul 98
     "     , low-cost  Brain               1997;120:729-737  Jul 97
     "     , PET scan  Ann Neur            1995;37:776-783   Jul 95
     "     ,    "      Ann Neur            1996;39:450-459   Jun 96
     "     ,    "      Brain               1997;120:1301-13  Oct 97
     "     ,    "      Brain               1997;120:1315-24  Oct 97
     "     ,  risk     Lancet              4 Apr 98:998-999  May 98
     "     ,  success  Ann Neur            1996;40:355-366   Oct 96
     "     ,     "     Neur                1997;1083-1090    Nov 97
     "     ,     "     Mov Disord          1997;12:752-755   Nov 97
     "     ,     "     J Neurosurg         1998;89:194-199   Sep 98
     "     ,  stroke   J Neurosurg         1997;97:955-960   Jan 98
     "     , technique J Neurosurg         1996;84:194-202   Jul 96
     "     ,     "     J Neurosurg         1996;85:1005-1012 Jan 97
     "     ,     "     J Neurosurg         1997:87:52-59     Aug 97
     "     ,     "     Neur                1998;50:258-265   Feb 98
     "     ,     "     J Neurosurg         1998;89:630-634   Oct 98
Paroxetine (Paxil)     Neur                1994;44:2406      Jan 95
Pathways, neural       Neur                1995;45S3:S28-S34 May 95
     "                 Neur                1996;1032-1036    Nov 96
Patient Diaries        Mov Disord          1997;12:1039-1041 Jan 98
Perception, auditory   Mov Disord          1997;12:655-664   Nov 97
     "    , visual     Brain               1996;119:79-87    May 96
Pergolide (Permax)     Neur                1995;45S3:S5      May 95
     "                 Neur                1995;45S3:S13-S21 May 95
     "                 Neur                1995;45S3:S22-S27 May 95
     "                 Mov Disord          1997;12:402-407   Aug 97
Personality and PD     Lancet              15 Feb 97:478     Mar 97
     "                 J Neur N'surg Psych 1998;64:262-266   Apr 98
PET diagnosis          Ann Neur            1994;36:759-764   Dec 94
     "                 Ann Neur            1994;2:176-182    Dec 94
     "                 J Neur N'surg Psych 1995;59:597-600   Jan 96
     "                 Neur                1995;45:1995-2004 Feb 96
     "                 Ann Neur            1996;39:450-459   Jun 96
     "                 Neur                1996;46:1430-1436 Jun 96
     "                 Neur                1996;46:1200-1205 Jun 96
     "                 Ann Neur            1996;39:650-658   Jun 96
     "                 Brain               1996;119:585-591  Jul 96
     "                 Neur                1996;47:462-466   Sep 96
     "                 Ann Neur            1996;40:873-884   Mar 97
     "                 Ann Neur            1997;41:58-64     Mar 97
     "                 Brain               1997;120:2187-95  Feb 98
     "                 J Neur N'surg Psych 1998;64:314-319   May 98
     "                 Mov Disord          1998;13:268-274   May 98
     "                 Mov Disord          1998;13;275-280   May 98
  "  research          Brain               1998;121:949-965  Jun 98
  "  scans, questioned Science             11 Apr 97:196-198 May 97
Pituitary, effects on  Clin Neuropharm     1996;19(1):72-80  Dec 97
     "     and PD      Ann Neur            1981;10:398-399   Jan 98
Porphyria and PD drugs J Neur N'surg Psych 1997;62:562       Jul 97
Post-encephalitis PD   Ann Neur            1997;42:356-359   Oct 97
Pramipexole (Mirapex)  PDF Newsletter      Spr 1996:1        Apr 96
     "                 JAMA                9 Jul 87:125-130  Aug 97
     "                 Neur                1997;49:162-168   Aug 97
     "                 Neur                1997;49:724-728   Oct 97
     "                 Neur                1997;49:1060-1065 Nov 97
     "                 Clin Neuropharm     1998;21:141-151   Jul 98
Preclinical period     J Neur N'surg Psych 1998;64:314-319   May 98
Pregnancy and PD       Mov Disord          1998;13:34-38     Mar 98
Prevalence             J Neur N'surg Psych 1997;62:10-15     Mar 97
     "                 Mov Disord          1998;13:626-632   Sep 98
Prions                 Science News        13 Apr 1996;228   May 96
Prodromal phase        Mov Disord          1997;12:871-876   Jan 98
Progenitor cells       Eng. & Sci (CIT)    Sept 95:26        Nov 95
Progression (case hist)NEJM                1996;334:116-118  Feb 96
     "                 JAMA                6 Mar 1996:716    Apr 96
     "                 JAMA                9 Oct 1196;1171   Nov 96
     "  , in putamen   Brain               1996;119:2097-103 Mar 97
Progressive Supranuc-  J Neur N'surg Psych 1996;60:589       Jun 96
     "     lear Palsy  J Neur N'surg Psych 1996;61:615-620   Aug 96
     "                 Neur                1996;47:1-9       Sep 96
     "                 Neur                1996;47:148-154   Sep 96
     "                 Brain               1997;120:65-74    Apr 97
     "                 Arch Neur           1997;54:1104-1108 Oct 97
Propranolol (Inderal)  Neur                1996;46:1548-1551 Jul 96
Propath program        Arch Neur           1996;53:881-884   Oct 96
Proton Magnetic Res.   J Neur N'Surg Psych 1997;62:239-242   Apr 97
     "    "      "     Mov Disord          1997;12:903-909   Jan 98
Prozac (fluoxetine)    Neur                1995;45:1855-1858 Nov 95
Pseudo-fatigue         Ann Neur            1998;44S1:189-196 Oct 98
Psychogenic PD         Arch Neur           1995;52:802-810   Sep 95
Psyllium               Mov Disord          1997;12:946-951   Jan 98
Quality of life        J Neur N'surg Psych 1996;61:71-74     Aug 96
     "                 Mov Disord          1997;12:916-922   Jan 98
Raclopride, in PET     Mov Disord          1997;12:33-38     Feb 97
Rapid-onset            Neur                1997;49:1066-1069 May 97
Rating scale, clinical Clin Neuropharm     1997;20:183-184   Sep 97
     "           "     Clin Neuropharm     1997;20:322-327   Sep 97
Reaction time          J Neur N'surg Psych 1995;59:499-506   Dec 95
     "                 Brain               1996;119:1689-1704Jan 97
Redundant pathways     J Neur N'surg Psych 1998;64:164-171   Apr 98
Reflex blink, and PD   J Neurosci          1996;16:7308-7330 Dec 96
Regeneration, brain    Lancet              16 Mar 1996:751   Apr 96
     "                 Science News        21 Sep 1996:180   Oct 96
     "                 Science             28 Feb 97;1318-19 Apr 97
     "                 Nat Med             1998;4:555-557    Jun 98
     "  , neural       Nat Med             1997;3:1329-1235  Jan 98
     "  , spinal cord  Lancet              21 Sep 1996:814   Oct 96
Registry (surveys)     Neur                1995;45:1991-1995 Feb 96
     "                 NEJM                1996;334:71-76    Feb 96
     "                 Neur                1995;45:2143-2146 Feb 96
     "                 Arch Neur           1996;53:66-71     Feb 96
Research priorities    JAMA                25 Oct 95:1257-8  Nov 95
Response time, levodopaNeur                1996;46:1055-1058 Jun 96
     "                 Neur                1996;46:1059-1062 Jun 96
Restless leg syndrome  JAMA                17 Jan 1996:      Feb 96
     "                 Neur                1996;47:1435-1441 Feb 97
     "                 Clin Neuropharm     1997;20:148-151   May 97
     "                 Mov Disord          1997;12:402-407   Aug 97
Rigidity               Mov Disord          1997;12:24-32     Feb 97
Risperidone            Mov Disord          1997;12:119-121   Feb 97
     "                 Mov Disord          1997;12:610-612   Sep 97
     "                 J Neur N'surg Psych 1998;64;135       Feb 98
Ropinirole (Requip)    Neur                1997;49:393-399   Oct 97
     "                 Mov Disord          1998;13:39-45     Mar 98
     "                 Mov Disord          1998;13:46-51     Mar 98
     "                 Clin Neuropharm     1998;21:101-107   Jun 98
     "                 Arch Neur           1998;55:1211-1216 Oct 98
     " and dyskinesia  Mov Disord          1998;13:234-241   May 98
     "  safety trial   Clin Neuropharm     1998;21:164-175   Jul 98
Salsolinol             Ann Neur            1996;40:119-122   Aug 96
     "                 Ann Neur            1998;43:212-216   Mar 98
     "                 Lancet              21 Mar 98:850-851 Apr 98
Selegiline, amphetamineLancet              1995;346:64       Oct 95
     "      , and AD   NEJM                14 Apr 97:1216-22 May 97
     "      , benefits Ann Neur            1995;37:95-98     Feb 95
     "      ,     "    Mov Disord          1997;12:175-182   May 97
     "      ,     "    Ann Neur            1997;41:833-834   Jul 97
     "      ,     "    Ann Neur            1998;43:613-617   Jun 98
     "      ,  DATATOP Arch Neur           1995;52:237-245   Apr 95
     "      ,     "    Arch Neur           1995;52:564-570   Nov 95
     "      ,     "    Ann Neur            1996;39:37-45     Mar 96
     "      ,     "    Ann Neur            1996;39:29-36     Mar 96
     "      ,     "    Ann Neur            1998;43:318-325   Apr 98
     "      ,  dosage  Mov Disord          1997;12:293-296   Aug 97
     "   , in favor of PDF Newsletter      Spr 1996:2        Apr 96
     "      , PET scan Ann Neur            1994;36:759-764   Dec 94
     "   , pro and con BMJ                 16 Mar 96:702-705 Apr 96
     "   ,   "  "   "  Ann Neur            1996;40:266-269   Sep 96
     "   ,   "  "   "  Ann Neur            1997;41:282-283   Mar 97
     " , protection by Ann Neur            1995;38:771-777   Jan 96
     " ,        "      J Neurochem         1997;68:33-39     Aug 97
     " ,        "      J Neurochem         1997;68:434-436   Aug 97
     " ,        "      Neur                1998;515:520-525  Sep 98
     "      , risks of BMJ                 16 Dec 95:1602-7  Jan 96
     "      ,   "      Ann Neur            1996;40:841-845   Mar 97
     "      ,   "      Neur                1997;48:662-667   Apr 97
     "      ,   "      Clin Neuropharm     1997;20:276-278   Sep 97
     "      ,   "      J Neur N'surg Psych 1997;63:228-234   Oct 97
     "      ,   "      Clin Neuropharm     1997;20:342       Feb 98
     "      ,   "      BMJ                 18 Apr 98;1191-96 May 98
     "      ,   "      BMJ                 25 Jul 98:252-255 Sep 98
     "      ,   "      J Neur N'surg Psych 1998;65:280-282   Sep 98
     "      ,   "      Neur                1998;51:825-830   Oct 98
     ", special review Neur                1996;47:Supp 3    Feb 97
Serotonin agonist      Neur                1997;49:1168-1170 Nov 97
     "       "         Mov Disord          1997;12:756-759   Nov 97
     "    antagonist   Clin Neuropharm     1997;20:300-310   Sep 97
     "    syndrome     Neur                1997;48:1070-1077 Mar 97
Sertoli cells          Nat Med             1997;3:1129-1132  Nov 97
Sexuality and PD       Mov Disord          1997;12:923-927   Jan 98
Shy-Drager             Ann Neur            1995;37:204-210   Mar 95
SIB-1508Y              Ann Neur            1998;43:311-317   Apr 98
     "                 Mov Disord          1998;13:637-642   Sep 98
Sinemet, dissolved     Mov Disord          1997;12:608-610   Sep 97
Sinemet CR             J Neur N'surg Psych 1995;58:ad        Jul 95
     "                 Lancet              11 Nov 95:1290    Dec 05
     "                 Mov Disord          1997;12:677-681   Nov 97
     "                 Clin Neuropharm     1994;17S2:1-6     May 98
Sjogren's syndrome     Mov Disord          1997;12:121-123   Feb 97
Sleep, violence in     Lancet              19 Apr 97:1150    Jun 97
  "      "             Neur                1998;51:526-529   Sep 98
  "  , benefit         Mov Disord          1997;12:506-508   Sep 97
  "  ,   "             Neur                1998;50:1332-1339 Jul 98
Smell, loss of         J Neur N'surg Psych 1997;62:436-446   Jul 97
  "  ,   "             Neur                1997;49:1262-1267 Jan 98
  "  ,   "             Arch Neur           1998;55:84-90     Feb 98
  "  ,   "             Mov Disord          1998;13:394-399   Jul 98
Smoking and PD         Neur                1995;45:1041      Sep 95
     "                 Neur                1995;58:294-298   Oct 95
     "                 Time                11 Mar 96:60      Apr 96
     "                 Lancet              24 Feb 96:527     Apr 96
     "                 Ann Neur            1996;39:378-381   Apr 96
     "                 Neur                1996;46:1275-1284 Jun 96
     "                 Neur                1997;49:1267-1272 Jan 98
     "   "  and MAO-B  Neur                1998;50:1458-1461 Jul 98
SPECT, diagnosis by    Neur                1996;46:278-285   Apr 96
     "                 Neur                1996;46:231-237   Apr 96
     "                 Brain               1997;120:103-110  Apr 97
     "                 J Neur N'surg Psych 1997;62:133-140   Apr 97
     "                 Mov Disord          1997;12:898-902   Jan 98
     "                 Mov Disord          1998;13:16-19     Mar 98
     "                 Mov Disord          1998;13:438-445   Sep 98
Speech therapy         Neur                1996;47:1496-1504 Feb 97
Stem cells, cultured   Science News        19 Jul 97:36      Aug 97
     "    , review of  Science             4 Apr 97:66-71    May 97
Stereotactic           J Neurosurg         1995;83:197-205   Aug 95
     "                 Science News        30 Mar 96:204     Apr 96
     "                 J Neurosurg         1998;88:777-781   Jun 98
Stimulation, chronic   Neur                1996;46:1150-1153 Jun 96
     "                 Arch Neur           1996;53:898-903   Oct 96
     "                 Neur                1997;49:1078-1083 Nov 97
Strategy, summary      Clin Neuropharm     1997;20:95-115    May 97
Strength, arm          Ann Neur            1996;39:79-88     Mar 96
     "                 Brain               1997;120:401-408  Jun 97
Striatonigral degener- Neur                1996;47:1032-1036 Nov 96
Stroke, help from      Mov Disord          1997;12:124-126   Feb 97
   "  , adverse effect J Neur N'surg Psych 1997;62:288-289   Apr 97
   "  ,    "           Neur                1997;49:707-710   Oct 97
   "  ,    "           Nat Med             1997;3:1129-1132  Nov 97
   "  ,    "           Mov Disord          1997;12:1035-1038 Jan 98
Surgery, holographic   J Neurosurg         1998;88:777-781   Jun 98
   "   , summary       J Neur N'surg Psych 1997;62:2-8       Mar 97
   "   ,   "           BMJ                 25 Apr 98:1259-60 Jun 98
Swallowing             Neur                1997;48:373-375   Mar 97
    "                  Mov Disord          1997;12:322-327   Aug 97
    "                  J Neur N'surg Psych 1997;63:579-583   Jan 98
Sweats, control of     Ann Neur            1995;37:120-122   Mar 95
Symmetrel (Amantadine) Neur                1996;46:1551-1556 Jul 96
Tachyphemia            Mov Disord          1997;12:302-305   Aug 97
Tacrine, PD symptoms   J Neur N'surg Psych 1996;61:324-325   Oct 96
Tactile acuity         Neur                1997;49:168-177   Aug 97
Tardive dyskinesia     Mov Disord          1997;12:119-121   Feb 97
    "      " , and PVP Lancet              15 Mar 97:777     Apr 97
Terguride              Clin Neuropharm     1996;19(1):72-80  Dec 97
Tetanus shot caused    J Neur N'surg Psych 1997;63:258       Oct 97
Thalamotomy            J Neur N'surg Psych 1996;60:564-571   Jun 96
     "                 Brain               1996;119:1717-27  Jan 97
     "                 Ann Neur            1997;41:108-111   Mar 97
     "                 J Neurosurg         1998;89:314-316   Sep 98
Thalamus, and tremor   Neur                1996;46:75-79     Mar 96
     "                 Neur                1996;46:1150-1153 Jun 96
Therapy, tutorial      Western J Med       1994;161:303-308  Jul 96
     "                 Postgrad Med        1996;99:52-68     Jul 96
     "                 Sci Amer Medicine   Part 11, Chap XV  Dec 97
     ", Kobe 1997 Sym  Neur                1998;51 Supp 2    Oct 98
Time, judgement of     Science News        17 Feb 96:101     Mar 96
     "                 Brain               1996;119:51-70    May 96
Tocopherol             Neur                1998;50:1900-1902 Aug 98
Tolcapone (Tasmar)     Neur                1997;48:81-87     Feb 97
     "                 Lancet              6 Sep 97:712      Oct 97
     "                 J Neur N'surg Psych 1997;63:421-428   Nov 97
     "                 Neur                1997;1066-1071    Nov 97
     "                 Mov Disord          1997;12:928-934   Jan 98
     "                 Clin Neuropharm     1997;20:531-541   Feb 98
     "                 Lancet              25 Apr 98:1221-22 Jun 98
     " , liver failure Lancet              19 Sep 98:958     Oct 98
     "   trial         Neur                1998;50S5:S15-S16 Aug 98
     "     "           Neur                1998;50S5:S31-S38 Aug 98
     "     "           Neur                1997;49:665-671   Aug 98
     "     "           J Neur N'surg Psych 1997;63:421-428   Aug 98
     "     "           Neur                1997;49:1066-1071 Aug 98
     "     "           Mov Disord          1998;13:643-647   Sep 98
     "     "           Arch Neur           1998;55:1089-1095 Oct 98
Tourette Syndrome      Mov Disord          1997:12:402-407   Aug 97
Toxins, environmental  Ann Neur            1994;36:765-770   Dec 94
     "                 Neur                1995;45:435-439   Apr 95
     "                 Neur                1995;45:2112      Feb 96
     "                 Neur                1997;48:1583-1588 Jul 97
Tracking, visual       Brain               1995;118:485-493  Jul 95
Transcranial mag. stim J Neurosci          1997;17:3178-3184 May 97
     "                 Mov Disord          1997;12:315-321   Aug 97
Tremor, action         Mov Disord          1998;13:56-60     Mar 98
     ", cerebellar     J Neur N'surg Psych 1997;62:282-284   Apr 97
     ", resting PD     Neur                1996;46:1359-1370 Jun 96
     ",   "            Neur                1998;51:803-810   Oct 98
     ", surgery for    J Neurosurg         1997;86:642-647   May 97
Trihexyphenidyl(Artane)Ann Neur            1997;41:133       Mar 97
Ubiquitin              Brain               1995;118:1447-49  Feb 96
UPDRS                  Mov Disord          1998;13:533-636   Sep 98
Urinary dysfunction    J Neur N'surg Psych 1997;62:507-511   Jul 97
     "      "          Mov Disord          1997;12:509-513   Sep 97
Valproate              Neur                1996;47:626-635   Oct 96
Vision abnormality     Neur                1995;45:1144-1148 Oct 95
   "       "           Mov Disord          1998;13:446-452   Sep 98
Visual perception      Brain               1996;119:79-87    May 96
   "       "           Brain               1997;120:2219-28  Feb 98
Visuomotor control     Neur                1998;50:1648-1654 Aug 98
Visuospatial attention Brain               1995;118:153-166  Jun 95
Vitamin D              Neur                1997;49:1273-1278 Jan 98
   "    E              Neur                1998;50:1900-1902 Aug 98
Voice tremor and DBS   Neur                1998;50:796-798   Apr 98
Walking stride length  Mov Disord          1998;13:61-69     Mar 98
   "       "   timing  Mov Disord          1998;13:428-437   Sep 98
Weight loss            Neur                1997;48:88-91     Feb 97
Wine and dementia      BMJ                 5 Apr 97:997      May 97
  "   "  longevity     BMJ                 28 Feb 98:648     Apr 98
Yawn when turning on   Neur                1998;50:823       Apr 98
Young onset            Neur                1996;47:225-230   Sep 96
   "    "              Mov Disord          1997;12:277-284   Aug 97
Zolpidem               Lancet              26 Apr 97:1222-23 Jun 97
    "                  Lancet              5 Jul 97:74       Aug 97
--
J. R. Bruman   (818) 789-3694
3527 Cody Road
Sherman Oaks, CA 91403-5013


Parkinsn's List Subject Index

Parkinsn's List Thread Index

Parkinsn's Archive Treasures Doctors, students, patients and caregivers find current Parkinson's information such as the Algorithm, Caregivers Handbook, and talks by respected Movement Disorder Specialists.

Mail converted by MHonArc 2.6.10
Site Hosting donated by He.net
&
Grant from The Parkinson Alliance